日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/03/29 | 5,910 | 5,950 | 5,870 | 5,900 | ±0 | ±0% | 136,900 |
| 2017/03/28 | 5,870 | 5,910 | 5,820 | 5,900 | +110 | +1.9% | 175,400 |
| 2017/03/27 | 5,790 | 5,840 | 5,760 | 5,790 | -70 | -1.2% | 138,300 |
| 2017/03/24 | 5,710 | 5,870 | 5,710 | 5,860 | +120 | +2.1% | 146,500 |
| 2017/03/23 | 5,670 | 5,750 | 5,630 | 5,740 | +20 | +0.3% | 333,300 |
| 2017/03/22 | 5,760 | 5,840 | 5,700 | 5,720 | -140 | -2.4% | 259,300 |
| 2017/03/21 | 5,890 | 5,930 | 5,820 | 5,860 | -70 | -1.2% | 246,500 |
| 2017/03/17 | 6,000 | 6,000 | 5,930 | 5,930 | -130 | -2.1% | 210,500 |
| 2017/03/16 | 6,000 | 6,080 | 5,990 | 6,060 | +30 | +0.5% | 143,000 |
| 2017/03/15 | 6,060 | 6,090 | 5,990 | 6,030 | -30 | -0.5% | 155,300 |
| 2017/03/14 | 6,090 | 6,130 | 6,020 | 6,060 | +40 | +0.7% | 203,500 |
| 2017/03/13 | 6,000 | 6,090 | 5,990 | 6,020 | +20 | +0.3% | 207,100 |
| 2017/03/10 | 5,940 | 6,030 | 5,930 | 6,000 | +60 | +1% | 402,600 |
| 2017/03/09 | 6,080 | 6,080 | 5,920 | 5,940 | -80 | -1.3% | 346,500 |
| 2017/03/08 | 6,060 | 6,080 | 5,990 | 6,020 | -30 | -0.5% | 281,400 |
| 2017/03/07 | 6,100 | 6,100 | 6,020 | 6,050 | -30 | -0.5% | 216,000 |
| 2017/03/06 | 6,100 | 6,120 | 6,050 | 6,080 | -50 | -0.8% | 165,400 |
| 2017/03/03 | 6,100 | 6,190 | 6,090 | 6,130 | -40 | -0.6% | 227,000 |
| 2017/03/02 | 6,190 | 6,200 | 6,090 | 6,170 | +20 | +0.3% | 337,200 |
| 2017/03/01 | 6,060 | 6,170 | 6,050 | 6,150 | +90 | +1.5% | 227,600 |
| 2017/02/28 | 6,130 | 6,140 | 6,050 | 6,060 | -70 | -1.1% | 277,200 |
| 2017/02/27 | 6,120 | 6,160 | 6,080 | 6,130 | -40 | -0.6% | 147,300 |
| 2017/02/24 | 6,200 | 6,220 | 6,130 | 6,170 | -30 | -0.5% | 158,700 |
| 2017/02/23 | 6,170 | 6,210 | 6,130 | 6,200 | +90 | +1.5% | 240,100 |
| 2017/02/22 | 6,100 | 6,170 | 6,050 | 6,110 | ±0 | ±0% | 141,400 |
| 2017/02/21 | 6,100 | 6,120 | 6,090 | 6,110 | ±0 | ±0% | 121,100 |
| 2017/02/20 | 6,090 | 6,140 | 6,000 | 6,110 | -30 | -0.5% | 146,300 |
| 2017/02/17 | 6,030 | 6,150 | 5,980 | 6,140 | +180 | +3% | 304,100 |
| 2017/02/16 | 5,950 | 6,020 | 5,920 | 5,960 | +20 | +0.3% | 215,700 |
| 2017/02/15 | 6,000 | 6,040 | 5,930 | 5,940 | -40 | -0.7% | 140,600 |
| 2017/02/14 | 6,000 | 6,060 | 5,950 | 5,980 | -40 | -0.7% | 251,600 |
| 2017/02/13 | 6,030 | 6,050 | 5,970 | 6,020 | +170 | +2.9% | 236,800 |
| 2017/02/10 | 5,830 | 5,870 | 5,770 | 5,850 | +90 | +1.6% | 186,400 |
| 2017/02/09 | 5,830 | 5,850 | 5,700 | 5,760 | +130 | +2.3% | 289,400 |
| 2017/02/08 | 5,580 | 5,670 | 5,550 | 5,630 | -30 | -0.5% | 187,200 |
| 2017/02/07 | 5,640 | 5,670 | 5,580 | 5,660 | +90 | +1.6% | 221,500 |
| 2017/02/06 | 5,630 | 5,630 | 5,470 | 5,570 | +40 | +0.7% | 318,200 |
| 2017/02/03 | 5,470 | 5,540 | 5,410 | 5,530 | +60 | +1.1% | 444,900 |
| 2017/02/02 | 5,460 | 5,540 | 5,220 | 5,470 | +10 | +0.2% | 792,800 |
| 2017/02/01 | 5,870 | 5,900 | 5,420 | 5,460 | -380 | -6.5% | 639,300 |
| 2017/01/31 | 5,850 | 5,900 | 5,810 | 5,840 | -40 | -0.7% | 193,800 |
| 2017/01/30 | 5,870 | 5,890 | 5,770 | 5,880 | -30 | -0.5% | 251,400 |
| 2017/01/27 | 5,950 | 5,950 | 5,900 | 5,910 | -70 | -1.2% | 170,200 |
| 2017/01/26 | 5,940 | 6,030 | 5,900 | 5,980 | +70 | +1.2% | 193,300 |
| 2017/01/25 | 5,900 | 5,910 | 5,830 | 5,910 | +10 | +0.2% | 127,100 |
| 2017/01/24 | 5,900 | 6,000 | 5,860 | 5,900 | -10 | -0.2% | 178,000 |
| 2017/01/23 | 5,830 | 5,960 | 5,800 | 5,910 | +20 | +0.3% | 199,000 |
| 2017/01/20 | 5,800 | 5,940 | 5,760 | 5,890 | +40 | +0.7% | 168,500 |
| 2017/01/19 | 5,860 | 5,860 | 5,770 | 5,850 | +40 | +0.7% | 122,700 |
| 2017/01/18 | 5,830 | 5,860 | 5,750 | 5,810 | +50 | +0.9% | 154,200 |
2001～
2050
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
